老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Akari Therapeutics PLC

11.04
-0.2600-2.30%
盤後：11.040.00000.00%18:41 EDT
成交量：4.00萬
成交額：44.72萬
市值：2,149.49萬
市盈率：-0.69
高：11.61
開：11.43
低：10.68
收：11.30
52周最高：49.60
52周最低：3.02
股本：194.70萬
流通股本：69.45萬
量比：0.30
換手率：5.76%
股息：- -
股息率：- -
每股收益(TTM):-15.9015
每股收益(LYR):-20.5537
淨資產收益率：-140.09%
總資產收益率：-19.10%
市淨率：1.16
市盈率(LYR):-0.54

資料載入中...

總覽公司新聞資訊公告
2020/11/16

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC問詢函

[Cover]Correspondence
2019/10/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多